USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Launch of Novel Immunoglobulin Products and Increasing Awareness of Therapeutic Options to Drive Double-digit Market Growth
08-Dec-2015
Asia Pacific
Market Research
MAEC-01-00-00-00
LS00108-AP-MR_16949
The global human plasma-derived therapeutics market is expected to experience a surge in demand due to an increase in the awareness of diseases and therapeutic options. The plasma-derived therapeutics market is segmented into albumin, immunoglobulins, coagulation factors, and other haemotologicals. The segments are discussed with supporting information on clinical trial timelines and results and historical and projected launch timelines. The report also focuses on the competitive landscape of both marketed and pipeline products and provides the market drivers and challenges.
Executive Summary
Recent Market Developments
Key M&As and Partnership Assessment
Companies to Watch
Methodology and Scope
Market Background—Segmentation
Market Background—Segmentation (continued)
Market Background—Segmentation (continued)
Market Segmentation
Market Segmentation (continued)
Market Forecasting
Competitive Landscape—Human Plasma-derived Therapeutics: Marketed Products
Competitive Landscape—Human Plasma-derived Therapeutics Market: Pipeline Products
Competitive Landscape—Count of Marketed and Pipeline Products
Competitive Landscape—Key Clinical Trials
Marketed Products Synopsis—Albumin
Marketed Products Synopsis—Other Haematologicals
Marketed Products Synopsis—Other Haematologicals (continued)
Marketed Products Synopsis—Coagulation Factors
Marketed Products Synopsis—Coagulation Factors (continued)
Marketed Products Synopsis—Coagulation Factors (continued)
Marketed Products Synopsis—Coagulation Factors (continued)
Marketed Products Synopsis—Immunoglobulins
Marketed Products Synopsis—Immunoglobulins (continued)
Marketed Products Synopsis—Immunoglobulins (continued)
Marketed Products Synopsis—Immunoglobulins (continued)
Marketed Products Synopsis—Immunoglobulins (continued)
Marketed Products Synopsis—Immunoglobulins (continued)
Pipeline Analysis—Approved
Pipeline Analysis—Phase 3
Pipeline Analysis—Phase 3 (continued)
Pipeline Analysis—Phase 2
Pipeline Analysis—Phase 1
Product Dashboard—ResusixTM, Entegrion, Inc.
Product Dashboard—CINRYZE® (new formulation), Shire
Product Dashboard—BIOSTATE® (new formulation), CSL Behring
Product Dashboard—Gammagard, Baxter
Conclusions and Recommendations
Legal Disclaimer
Plasma—Overview
Plasma—Overview (continued)
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Sumedha Pareek |
| WIP Number | MAEC-01-00-00-00 |
| Is Prebook | No |
A Product and Pipeline Analysis of the Human Plasma-derived Therapeutics Market
$6,000.00
Special Price $4,500.00 save 25 %